Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume 62, Issue 11, Pages 1523-1531
Publisher
Springer Science and Business Media LLC
Online
2023-10-12
DOI
10.1007/s40262-023-01298-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pharmacokinetic Alterations Associated with Critical Illness
- (2023) Diana Morales Castro et al. CLINICAL PHARMACOKINETICS
- Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study
- (2022) Melina Verso et al. EUROPEAN JOURNAL OF CANCER
- 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
- (2022) Dominique Farge et al. LANCET ONCOLOGY
- Chronic kidney disease in cancer patients, the analysis of a large oncology database from Eastern Europe
- (2022) Mircea Ciorcan et al. PLoS One
- Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database
- (2022) Stéphanie Pochet et al. Scientific Reports
- Patterns and Trends of Herbal Medicine Use among Patients with Gynecologic Cancer
- (2021) Anna-Katharin Theuser et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
- (2021) Karlyn A. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy
- (2021) Tzu‐Fei Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review
- (2021) Paolo Bossi et al. Nutrients
- Direct Acting Oral Anticoagulants Following Gastrointestinal Tract Surgery
- (2021) Hakeam A. Hakeam et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
- (2021) Longfei Lin et al. Journal of Hematology & Oncology
- The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding
- (2020) Sarah Hanigan et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants
- (2020) Michal Ariela Raz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Drug–Drug Interactions with Direct Oral Anticoagulants
- (2020) Kathrin I. Foerster et al. CLINICAL PHARMACOKINETICS
- Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
- (2020) Ashley Chen et al. Journal of the American Heart Association
- Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low‐molecular‐weight heparin
- (2020) Sandip H. Patel et al. CANCER
- Direct oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis
- (2020) V. Mai et al. PHARMACOLOGICAL RESEARCH
- Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system
- (2020) Nicholas Jakowenko et al. THROMBOSIS RESEARCH
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- (2019) Nigel S. Key et al. JOURNAL OF CLINICAL ONCOLOGY
- Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First‐Line Palliative Chemotherapy
- (2019) Soojung Hong et al. ONCOLOGIST
- Oral Anticoagulation in Patients With Liver Disease
- (2018) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH
- (2018) B. T. Samuelson Bannow et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting
- (2018) Hanno Riess et al. ONCOLOGIST
- Antithrombotic medication in cancer-associated thrombocytopenia: current evidence and knowledge gaps
- (2018) A. Leader et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure
- (2018) Roberto Padrini EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis
- (2017) K. Boonyawat et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
- (2017) Hakeam A. Hakeam et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism
- (2017) Laurent Bertoletti et al. PHARMACOLOGICAL RESEARCH
- Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies
- (2017) Silvy Laporte et al. PHARMACOLOGICAL RESEARCH
- Epidemiology of cancer-associated venous thrombosis
- (2013) J. F. Timp et al. BLOOD
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting
- (2013) Jóhann P. Hreinsson et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism
- (2013) José Antonio Nieto et al. THROMBOSIS RESEARCH
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- The use of herbal medicines by people with cancer: a cross-sectional survey
- (2011) S Damery et al. BRITISH JOURNAL OF CANCER
- How Many Cancer Patients Use Complementary and Alternative Medicine
- (2011) Markus Horneber et al. INTEGRATIVE CANCER THERAPIES
- Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry
- (2010) J. A. NIETO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Association of a Cancer Diagnosis With Vulnerability and Frailty in Older Medicare Beneficiaries
- (2009) S. G. Mohile et al. JNCI-Journal of the National Cancer Institute
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started